1
|
Shen Z, Liu B, Zhu Z, Du J, Zhou Z, Pan C, Chen Y, Yin C, Luo Y, Li H, Chen X. Construction of a Triple-Gene Deletion Mutant of Orf Virus and Evaluation of Its Safety, Immunogenicity and Protective Efficacy. Vaccines (Basel) 2023; 11:vaccines11050909. [PMID: 37243014 DOI: 10.3390/vaccines11050909] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2023] [Revised: 04/17/2023] [Accepted: 04/25/2023] [Indexed: 05/28/2023] Open
Abstract
Contagious ecthyma is a zoonotic disease caused by the orf virus (ORFV). Since there is no specific therapeutic drug available, vaccine immunization is the main tool to prevent and control the disease. Previously, we have reported the construction of a double-gene deletion mutant of ORFV (rGS14ΔCBPΔGIF) and evaluated it as a vaccine candidate. Building on this previous work, the current study reports the construction of a new vaccine candidate, generated by deleting a third gene (gene 121) to generate ORFV rGS14ΔCBPΔGIFΔ121. The in vitro growth characteristics, as well as the in vivo safety, immunogenicity, and protective efficacy, were evaluated. RESULTS: There was a minor difference in viral replication and proliferation between ORFV rGS14ΔCBPΔGIFΔ121 and the other two strains. ORFV rGS14ΔCBPΔGIFΔ121 induced continuous differentiation of PBMC to CD4+T cells, CD8+T cells and CD80+CD86+ cells and caused mainly Th1-like cell-mediated immunity. By comparing the triple-gene deletion mutant with the parental strain and the double-gene deletion mutant, we found that the safety of both the triple-gene deletion mutant and the double-gene deletion mutant could reach 100% in goats, while the safety of parental virus was only 50% after continually observing immunized animals for 14 days. A virulent field strain of ORFV from an ORF scab was used in the challenge experiment by inoculating the virus to the hairless area of the inner thigh of immunized animals. The result showed that the immune protection rate of triple-gene deletion mutant, double-gene mutant, and the parental virus was 100%, 66.7%, and 28.6%, respectively. In conclusion, the safety, immunogenicity, and immune-protectivity of the triple-gene deletion mutant were greatly improved to 100%, making it an excellent vaccine candidate.
Collapse
Affiliation(s)
- Zhanning Shen
- Animal Science and Techology College, Beijing University of Agriculture, Beijing 102208, China
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Bo Liu
- China Institute of Veterinary Drug Control, Beijing 100081, China
- International Atomic Energy Agency, Vienna International Centre, P.O. Box 100, A-1400 Vienna, Austria
| | - Zhen Zhu
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Jige Du
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Zhiyu Zhou
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Chenfan Pan
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Yong Chen
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Chunsheng Yin
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Yufeng Luo
- China Institute of Veterinary Drug Control, Beijing 100081, China
| | - Huanrong Li
- Animal Science and Techology College, Beijing University of Agriculture, Beijing 102208, China
| | - Xiaoyun Chen
- China Institute of Veterinary Drug Control, Beijing 100081, China
| |
Collapse
|
2
|
Zhu Z, Qu G, Du J, Wang C, Chen Y, Shen Z, Zhou Z, Yin C, Chen X. Construction and characterization of a contagious ecthyma virus double-gene deletion strain and evaluation of its potential as a live-attenuated vaccine in goat. Front Immunol 2022; 13:961287. [PMID: 36119021 PMCID: PMC9478544 DOI: 10.3389/fimmu.2022.961287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2022] [Accepted: 08/10/2022] [Indexed: 11/13/2022] Open
Abstract
Contagious ecthyma is a highly contagious viral disease with zoonotic significance caused by orf virus (ORFV) that affects domestic, ruminants and humans. Live attenuated virus and attenuated tissue culture vaccines are widely used in the fight against ORFV, however, the conventional attenuated vaccine strains have many drawbacks. The aim of this project was to construct a promising contagious ecthyma vaccine strain with safety, high protection efficacy and accessibility by genetic manipulation to against the disease. Using a natural ORFV-GS14 strain as the parental virus, recombinant virus, rGS14-ΔCBP-ΔGIF, with double deletions in the genes encoding the chemokine binding protein (CBP) and granulocyte/macrophage colony-stimulating factor inhibitory factor (GIF) was generated and characterized in vitro and in vivo. Results showed that the growth kinetics curve of rGS14-ΔCBP-ΔGIF and parental virus was consistent, both reaching plateau phase at 48 h post infection, which indicated that the double deletion of cbp and gif genes had little impact on the replication properties of the recombinant virus in primary goat testis (PGT) cell cultures compared with the parental virus. The safety of the double gene-deleted virus was evaluated in lambs. The lambs were monitored for 21 days post infection of the recombinant virus and no ORFV associated symptoms were observed in 21 days post-infection except for slight fever and anorexia in 5 days post-infection, and all lambs inoculated with either recombinant virus or PBS exhibited no clinical signs. To assess the protection efficacy of the rGS14-ΔCBP-ΔGIF, groups of four lambs each were inoculated with rGS14-ΔCBP-ΔGIF, rGS14-ΔCBP, rGS14-ΔGIF or PBS and challenged by a wild type virulent ORFV strain that was isolated from proliferative scabby lesions tissues of infected goat at 21-day post-inoculation. During 14 days post-challenging, lambs inoculated with rGS14-ΔCBP-ΔGIF all remained healthy with unimmunized group all infected, while the single gene-deleted viruses only protected 40% to 50% animals. These results indicated that the double gene-deleted recombinant virus could provide complete protection against virulent ORFV challenging. In conclusion, the double gene-deleted recombinant virus strain, rGS14-ΔCBP-ΔGIF, would be a promising candidate vaccine strains with safety, high protection efficacy and availability.
Collapse
Affiliation(s)
- Zhen Zhu
- China Institute of Veterinary Drug Control, Beijing, China
| | - Guanggang Qu
- Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China
| | - Jige Du
- China Institute of Veterinary Drug Control, Beijing, China
| | - Changjiang Wang
- Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China
| | - Yong Chen
- China Institute of Veterinary Drug Control, Beijing, China
| | - Zhanning Shen
- China Institute of Veterinary Drug Control, Beijing, China
| | - Zhiyu Zhou
- China Institute of Veterinary Drug Control, Beijing, China
| | - Chunsheng Yin
- China Institute of Veterinary Drug Control, Beijing, China
| | - Xiaoyun Chen
- China Institute of Veterinary Drug Control, Beijing, China
| |
Collapse
|